Rezolute (RZLT) Amortization - Intangibles (2013 - 2014)

Rezolute (RZLT) reported Amortization - Intangibles of $886.0 for Q1 2014, little changed sequentially from $886.0 in Q4 2013.

Rezolute (RZLT) Amortization - Intangibles (2013 - 2014) Analysis & Trends

Rezolute (RZLT) has 2 years of Amortization - Intangibles data on file, last reported at $886.0 in Q1 2014.

For the quarter ending Q1 2014, Amortization - Intangibles changed N/A year-over-year to $886.0; the trailing twelve-month figure through Mar 2014 stood at $2953.0 (changed N/A YoY), and the FY2013 full-year result was $295.0, changed N/A from the prior year.
Amortization - Intangibles held at $886.0 in Q1 2014, from $886.0 in the prior quarter.
In the past five years, Amortization - Intangibles ranged from a high of $886.0 in Q3 2013 to a low of $295.0 in Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Rezolute	31,153.77	31,153.77	-

Download Data